AFYREN lands €13 million venture debt to scale bio-based acids
What's the deal? French green chemistry company AFYREN has secured a €12.5 million venture debt facility from BNP Paribas. The financing is backed by the European Investment Fund under the European Union's InvestEU programme, which mobilises sustainable investment across Europe.
What does the company do? AFYREN converts non-food plant waste into low-carbon organic acids, aiming to replace fossil-based products. Those renewable ingredients serve food and animal feed, cosmetics, and fine chemicals.
Why now? Venture debt lets growing companies fund expansion and cover operating costs without selling equity. The loan comes from BNP Paribas Growth Capital & SolutionsDealroom has a profile for this one. Try Dealroom →, a team that funds European businesses focused on clean technology and sustainability.
What's the endgame? The money supports AFYREN as it scales production at its main plant in France. It also aims to accelerate sales as international markets seek non-petroleum chemical alternatives.
The signal: Debt financing is increasingly common for bioeconomy scaleups looking to fund capital-heavy production without diluting shareholders. For AFYREN, the deal marks a step up from its previous raise as it moves from proving its technology to commercialising it.
Read more: worldbiomarketinsights.com
Image credit: Oregon State University
